POSJELTY Trademark

Trademark Overview

On Wednesday, April 7, 2021, a trademark application was filed for POSJELTY with the United States Patent and Trademark Office. The USPTO has given the POSJELTY trademark a serial number of 90628289. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, October 7, 2024. This trademark is owned by UroGen Pharma Ltd.. The POSJELTY trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations and compositions for the treatment of bladder cancer
posjelty

General Information

Serial Number90628289
Word MarkPOSJELTY
Filing DateWednesday, April 7, 2021
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, October 7, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 4, 2022

Trademark Statements

Goods and Servicespharmaceutical preparations and compositions for the treatment of bladder cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, July 14, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameUroGen Pharma Ltd.
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressRa'anana 4365007
IL
Party NameUroGen Pharma Ltd.
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressRa'anana 4365007
IL

Trademark Events

Event DateEvent Description
Wednesday, July 14, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, April 10, 2021NEW APPLICATION ENTERED
Wednesday, November 24, 2021ASSIGNED TO EXAMINER
Wednesday, November 24, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 15, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, August 12, 2022SOU EXTENSION 1 GRANTED
Tuesday, January 4, 2022PUBLISHED FOR OPPOSITION
Tuesday, January 4, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 1, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, August 12, 2022SOU TEAS EXTENSION RECEIVED
Friday, August 12, 2022SOU EXTENSION 1 FILED
Tuesday, February 7, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, August 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 7, 2023SOU EXTENSION 2 GRANTED
Tuesday, February 7, 2023SOU EXTENSION 2 FILED
Wednesday, May 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 9, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 8, 2023SOU TEAS EXTENSION RECEIVED
Monday, May 8, 2023SOU EXTENSION 3 FILED
Monday, May 8, 2023SOU EXTENSION 3 GRANTED
Wednesday, August 23, 2023ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Wednesday, January 31, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, January 31, 2024SOU EXTENSION 4 FILED
Wednesday, January 31, 2024SOU EXTENSION 4 GRANTED
Friday, February 2, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 7, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, October 7, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

posjelty bladder cancer treatment compositions preparations pharmaceutical